INmune Bio Inc
Ownership
Ownership Structure
Who owns INmune Bio Inc (INMB)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 84.0% of the shares are freely tradable; institutional investors hold 19.7%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 4.30 | 1,194,112 | -1.5 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.48 | 687,015 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 1.78 | 494,969 | +12.1 | 03/31/2026 |
| State Street Corp | 1.05 | 290,879 | -16.2 | 03/31/2026 |
| AQR Capital Management LLC | 0.97 | 270,317 | +1,217.4 | 03/31/2026 |
| UBS Group AG | 0.91 | 253,340 | +316.7 | 03/31/2026 |
| The Goldman Sachs Group Inc | 0.83 | 231,586 | +310.1 | 03/31/2026 |
| Susquehanna International Group, LLP | 0.70 | 194,391 | -22.5 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 1.77 | 490,268 | +0.0 | 07/31/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.71 | 195,995 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.